Clinical Trials Directory

Trials / Completed

CompletedNCT03209843

Post-stenting Assessment of Reendothelialization With OFDI After CTO Procedure (PERFECTO)

Post-stenting Assessment of Reendothelialization With OFDI After CTO Procedure

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
122 (actual)
Sponsor
Poitiers University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of PERFECTO is to assess the reendothelialization at 3 months after successfully CTO percutaneous intervention (PCI) with new generation drug eluting stent (DES) by OFDI analysis. Designed as a multicentric, observational and prospective study which will be conducted at University Hospital of Poitiers (France), a systematic OFDI analysis will be realized immediately after CTO-PCI and at 3 months. Known as major predictive factors of stent thrombosis, percentages of malapposition, uncovered struts and neointimal hyperplasia proliferation will be measured over the entire length of each stent implanted combining in a composite primary endpoint.

Conditions

Interventions

TypeNameDescription
PROCEDUREPercutaneous recanalization of chronic total occlusionPercutaneous recanalization of chronic total occlusion followed by immediate systematic coronary optical frequency domain imaging (OFDI) at inclusion. Intra-individual post stenting assessment of reendothelialization with a second coronary angiography with OFDI analysis at 3 months.

Timeline

Start date
2018-03-07
Primary completion
2021-02-12
Completion
2021-02-12
First posted
2017-07-06
Last updated
2021-04-14

Locations

7 sites across 1 country: France

Source: ClinicalTrials.gov record NCT03209843. Inclusion in this directory is not an endorsement.